Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Oct 15;224(2):234–237. doi: 10.1016/j.ajog.2020.10.017

A marked decrease in preterm deliveries during the coronavirus disease 2019 pandemic

Raanan Meyer 1,2, Yossi Bart 1,2, Abraham Tsur 1,2, Yoav Yinon 1,2, Lior Friedrich 3, Nitzan Maixner 3, Gabriel Levin 4
PMCID: PMC7560113  PMID: 33069683

Objective

Previous studies comparing the coronavirus disease 2019 pandemic period with prepandemic periods reported either no change or a decrease in extremely preterm birth (PTB) rates during the pandemic.1 , 2 These studies evaluated a limited number of potential PTB confounders and a short pandemic period. We aimed to determine the change in the PTB rate and neonatal outcomes during the pandemic period compared with that in the prepandemic periods by evaluating multiple obstetrical characteristics during more than 3 pandemic months.

Study Design

We compared maternal, obstetrical, and neonatal outcomes of singleton pregnancies at the Sheba Medical Center, Israel, during 3 periods: from March 20, 2020 (date of implementation of governmental state of lockdown), to June 27, 2020 (group 1); a parallel period in 2019 (group 2); and parallel annual periods in 2011–2019 (group 3) (Table 1 ). We also compared maternal and pregnancy characteristics during the pandemic and corresponding prepandemic periods in 2019 between pregnancies complicated by PTB at <34 0/7 and ≥34 0/7 weeks’ gestation (Table 2 ). Multivariate regression analysis was performed to study independent factors associated with PTB. The institutional review board approved this study (7068-20-SMC; March 30, 2020).

Table 1.

Comparison of maternal, obstetrical, and delivery characteristics and neonatal outcomes between the pandemic (March 2020 to June 2020) and prepandemic periods (from March 2019 to June 2019)

Characteristic COVID-19 period (n=2594) Prepandemic period (2019; n=2742) OR (95% CI)a P value Prepandemic-matched period (2011–2019; n=28,686) OR (95% CI)a P value
Maternal characteristics
Age, y 32.00±5.40 32.00±5.10 .329 32.00±5.10 .018
Prepregnancy BMI, kg/m2 23.50±4.60 23.60±4.70 .285 23.30±4.40 .011
Predelivery BMI, kg/m2 28.20±4.50 28.40±4.50 .119 28.20±4.40 .381
Weight gain, kg 13.00±5.40 13.00±5.90 .190 13.00±5.50 <.001
Immigrant 387 (14.90) 440 (16.00) .257 4772 (16.60) 0.88 (0.79–0.99) .024
Smoking 107 (4.10) 117 (4.30) .796 1386 (4.80) .106
Parity 1.00±1.50 1.00±1.60 .584 1.00±1.40 .001
Nulliparous 877 (33.80) 952 (34.70) .484 10,271 (35.80) 0.92 (0.85–0.99) .042
Previous cesarean delivery 425 (16.40) 457 (16.70) .781 4551 (15.90) .489
Positive SARS-CoV-2b test 13
Assisted reproductive technology 221 (8.50) 238 (8.70) .835 2082 (7.30) 1.19 (1.03–1.39) .018
Diabetes 297 (11.40) 285 (10.40) .216 2615 (9.10) 1.28 (1.14–1.47) <.001
Hypertensive disease 117 (4.50) 125 (4.60) .932 1118 (3.90) .125
Hemoglobin before delivery, g/dL 12.19±1.10 11.98±1.10 <.001 11.92±1.10 <.001
Hemoglobin of <11.0 g/dL before delivery 357 (13.80) 5289 (18.40) 0.87 (0.63–0.79) <.001 503 (18.30) 0.71 (0.61–0.82) <.001
Platelets before delivery, K/μL 201.00±57.20 211.00±59.90 <.001 205.00±57.10 <.001
White blood cell count before delivery, K/μL 10.90±3.00 11.10±3.30 .264 11.40±3.20 <.001
Fibrinogen before delivery, mg/dL 474.00±100.90 468.00±96.90 .298 446.00±84.90 <.001
Delivery characteristics
Induction of labor 295 (11.40) 286 (10.40) .270 2793 (9.70) 1.19 (1.05–1.35) .007
Intrapartum fever 35 (1.30) 30 (1.10) .396 281 (1.00) .071
Gestational age at delivery, wk 39 1/7±1 6/7 39 0/7±2 0/7 .004 39 1/7±2 1/7 .684
 <37 0/7 174 (6.70) 220 (8.00) .066 2060 (7.20) .370
 <34 0/7 32 (1.20) 74 (2.70) 0.45 (0.30–0.68) <.001 592 (2.10) 0.60 (0.41–0.85) .004
 <32 0/7 20 (0.80) 45 (1.60) 0.47 (0.27–0.79) .004 379 (1.30) 0.58 (0.37–0.92) .017
Spontaneous delivery 1746 (67.30) 1812 (66.10) .352 19,961 (69.60) 0.90 (0.82–0.98) .014
Operative vaginal delivery 187 (7.20) 197 (7.20) .972 1735 (6.00) 1.22 (1.04–1.43) .018
Cesarean delivery 661 (25.50) 733 (26.70) .299 6990 (24.40) .206
Intrapartum cesarean delivery 277 (41.90) 325 (44.30) .366 3083 (44.10) 0.276
Neonatal outcomes
Birthweight, g 3230±511 3196±544 .020 3205±533 .026
Composite neonatal outcomec 118 (4.50) 163 (5.90) 0.76 (0.59–0.96) .023 1530 (5.30) .087
Stillbirth 22 (0.80) 22 (0.80) .853 290 (1.00) .424
Death in 30 d 3 (0.10) 4 (0.10) 1.0 23 (0.10) .427
Mechanical ventilation 24 (0.90) 23 (0.80) .736 271 (0.90) .922
Hypoxic-ischemic encephalopathy 2 (0.10) 2 (0.10) 1.0 27 (0.10) 1.0
Convulsions 1 (0.01) 5 (0.20) .220 25 (0.10) .720
Asphyxia 0 (0.00) 1 (0.01) 1.0 32 (0.10) .108
1-min Apgar score of <5 9 (0.30) 13 (0.50) .469 193 (0.70) 0.51 (0.26–1.01) .060
5-min Apgar score of <7 8 (0.30) 8 (0.30) .911 113 (0.40) .502
Neonatal intensive care unit admission 78 (3.00) 123 (4.50) 0.66 (0.50–0.88) .005 1048 (3.70) .091

Data are presented as mean±standard deviation or number (percentage).

OR was calculated only for significantly different categorical variables.

Apgar, appearance, pulse, grimace, activity, and respiration; BMI, body mass index; CI, confidence interval; COVID-19, coronavirus disease 2019; OR, odds ratio, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Meyer. Preterm deliveries during the coronavirus disease pandemic. Am J Obstet Gynecol 2021.

a

Prepandemic data were compared with COVID-19 period data

b

SARS-CoV-2 infection was evaluated only during the COVID-19 pandemic. During the study period, only women from endemic areas or women with symptoms of COVID-19 were screened for infection

c

Composite neonatal outcome consisted of the occurrence of any of the following: stillbirth, neonatal death during the first 30 days, mechanical ventilation, hypoxic-ischemic encephalopathy, convulsions, asphyxia, 1-minute Apgar score of <5, 5-minute Apgar of <7, and neonatal intensive care unit admission.

Table 2.

Comparison of maternal, obstetrical, and delivery characteristics and neonatal outcomes between pregnancies complicated by PTB at <34 0/7 and ≥34 0/7 weeks’ gestation during the pandemic (March 2020 to June 2020) and prepandemic periods (from March 2019 to June 2019)

Characteristic Delivery at <34 0/7 wk (n=106) Delivery at ≥34 0/7 wk (n=5230) OR (95% CI) P value aOR (95% CI)a P value
Age, y 32.00±7.30 32.00±5.40 .430
Prepregnancy BMI, kg/m2 23.10±3.90 23.60±4.60 .396
Predelivery BMI, kg/m2 26.20±4.50 28.40±4.50 <.001b
Weight gain, kg 9.00±3.60 13.00±5.70 <.001b 0.93 (0.90–0.97)c <.001b
Immigrant 13 (12.3) 814 (15.6) .353
Smoking 8 (7.5) 216 (4.1) .082
COVID-19 period 32 (30.2) 2562 (49.0) 0.45 (0.29–0.68) <.001b 0.29 (0.15–0.56) .001b
Parity 1.00±1.60 1.00±1.50 .509
Nulliparous 45 (42.5) 1784 (34.1) .073
Previous cesarean delivery 23 (21.7) 859 (16.4) .148
Assisted reproductive technology 21 (19.8) 438 (8.4) 2.70 (1.66–4.40) <.001b 3.57 (1.92–6.61) <.001b
Diabetes 11 (10.4) 571 (10.9) .860
Hypertensive disease 8 (7.5) 234 (4.5) .132
Hemoglobin before delivery, g/dL 11.23±2.20 12.10±1.10 <.001b
Hemoglobin of <11 g/dL before delivery 33 (31.1) 827 (15.8) 2.40 (1.58–3.65) <.001b 2.89 (1.64–5.10) <.001b
Induction of labor 26 (24.5) 555 (10.6) 2.73 (1.74–4.29) <.001b 3.41 (1.90–6.43) <.001b
Intrapartum fever 2 (1.9) 63 (1.2) .372

Data are presented as mean±standard deviation or number (percentage).

aOR, adjusted odds ratio; BMI, body mass index; COVID-19, coronavirus disease 2019; OR, odds ratio; PTB, preterm birth.

Meyer. Preterm deliveries during the coronavirus disease pandemic. Am J Obstet Gynecol 2021.

a

aOR following multivariate regression analysis include the following factors: weight gain, COVID-19 period, assisted reproductive technology, hemoglobin before delivery, and induction of labor

b

P<.05

c

For every kg increase in weight gain.

Results

There were 2594 deliveries during the pandemic period (group 1) and 2742 and 28,686 deliveries in the prepandemic periods (groups 2 and 3, respectively). Maternal and obstetrical characteristics did not differ between groups 1 and 2. Predelivery hemoglobin levels were higher in the pandemic period. PTB rate at <34 0/7 weeks’ gestation was significantly lower in the pandemic period than in the parallel period (group 2) (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.30–0.68; P<.001), as was the rate of composite neonatal outcome (OR, 0.76; 95% CI, 0.59–0.96; P=.023). Age, body mass index, parity, diabetes rates, and hematologic characteristics differed between groups 1 and 3 with significantly higher predelivery hemoglobin levels in group 1. PTB rate at <34 0/7 weeks’ gestation was lower in the pandemic period (OR, 0.60; 95% CI, 0.41–0.85; P=.004). On multivariate regression analysis, childbirth during the pandemic period was independently associated with a decreased risk of delivery at <34 0/7 weeks’ gestation (adjusted OR, 0.29; 95% CI, 0.15–0.56; P=.001).

Conclusion

We observed more than 50% reduction in the rate of PTB at <34 0/7 weeks’ gestation, possibly resulting in improved neonatal outcomes.

Explanations for the lower PTB rate include reduced iatrogenic PTBs, avoidance of infections, or reduced stress level related to the lockdown policy. Another suggested etiology is heme oxygenase-1 (HO-1) induction, caused by relative hypoxia resulting from wearing a face mask during the pandemic period. HO-1 enhances hemoglobin production and has been shown to reduce spontaneous PTB rates.3 , 4 However, the clinical significance of hemoglobin level differences is questionable.

Although a Danish study reported lower rates of PTB at ≤27 6/7 weeks’ gestation during the pandemic, it evaluated only 1 month of the pandemic period and was based on a national registry.1 Another study has found a trend (P=.07) toward higher PTB rates during the pandemic.2 However, the sample size was limited, and the prepandemic period comparison was not parallel, potentially introducing seasonal effects.5

Further research is required to better understand the pathogenesis underlying lower PTB rates during the pandemic period.

Footnotes

The authors report no conflict of interest.

The source of this research is the Chaim Sheba Medical Center, Ramat Gan, Israel.

References

  • 1.Hedermann G., Hedley P.L., Bækvad-Hansen M. Danish premature birth rates during the COVID-19 lockdown. Arch Dis Child Fetal Neonatal Ed. 2020 doi: 10.1136/archdischild-2020-319990. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Khalil A., von Dadelszen P., Draycott T., Ugwumadu A., O’Brien P., Magee L. Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic. JAMA. 2020;324:705–706. doi: 10.1001/jama.2020.12746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Neubauer J.A., Sunderram J. Heme oxygenase-1 and chronic hypoxia. Respir Physiol Neurobiol. 2012;184:178–185. doi: 10.1016/j.resp.2012.06.027. [DOI] [PubMed] [Google Scholar]
  • 4.Tsur A., Kalish F., Burgess J. Pravastatin improves fetal survival in mice with a partial deficiency of heme oxygenase-1. Placenta. 2019;75:1–8. doi: 10.1016/j.placenta.2018.11.001. [DOI] [PubMed] [Google Scholar]
  • 5.Bekkar B., Pacheco S., Basu R., DeNicola N. Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.8243. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Obstetrics and Gynecology are provided here courtesy of Elsevier

RESOURCES